Articles

RELX

More than 1100 people came together virtually on 18 June 2024 for the tenth edition of the RELX SDG Inspiration Day: "In the Age of AI: Information to Advance the UN Sustainable Development Goals (SDGs)." The annual online event brings together thought leaders, corporate representatives, students, investors, governments, and NGOs to explore pressing issues, gain practical insight, and inspire action on the United Nations Sustainable Development Goals (SDGs).

Elsevier,

Archives of Gerontology and Geriatrics Plus, Volume 1, Issue 4, December 2024, 100072

This study reveals that the estimation of lipids and carotenoid levels could support the early diagnosis or help to understand the pathophysiology of Alzheimer's Disease.

Elsevier,

Global Ecology and Conservation, Volume 52, August 2024

This paper highlights the importance for conservation biologists and on-the-ground practitioners to engage more with local pastoralists to tackle the complex and infrequently described conflicts on how best to implement protective policies.
Elsevier,

Archives of Gerontology and Geriatrics, Volume 123, August 2024

Interaction of human and socially assistive robot can have applicability in actual settings, and adoption to function in human environment for Alzheimer's disease. This review revealed that there are still several technical challenges that must be addressed in future advancements before being integrated in real life of individuals with Alzheimer's disease. The results will help move towards the establishment of best practices for the development of human and socially assistive robot interaction for Alzheimer's disease and, in turn, help enhance the experience of people suffering from this disease.
Elsevier,

Heliyon, Volume 10, 15 August 2024

This study focuses on neuroimaging methods such as structural magnetic resonance imaging (sMRI) and fluorodeoxyglucose positron emission tomography (FDG-PET) have been used to diagnose and categorize AD
Elsevier,

Advances in Nutrition, Volume 15, August 2024

Dementia is a global leading cause of disability and death among older adults, and there is a need to carefully evaluate existing evidence on related risk factors to guide future research. This review summarized and evaluated the most updated evidence on associations of various magnesium forms (supplements, dietary intake, and biomarkers) with cognitive outcomes in adults, based on evidence from randomized controlled trials and cohort studies.
Elsevier,

Archives of Gerontology and Geriatrics, Volume 123, August 2024

Olfactory impairments are notably present in MCI, particularly with significant declines in odor identification, similar to the primary sensory deficit observed in AD, suggesting the incorporation of odor identification tests for early AD detection.
Elsevier,

Pharmacological Research, Volume 206, August 2024

This study investigates the relationship between antidiabetic drugs and Alzheimer’s disease (AD) in a population-based sample.
Elsevier,

Behavioural Brain Research, Volume 471, 5 August 2024

This review discusses the impact of Apolipoprotein-E4 (ApoE4) on cognitive performance in targeted-replacement human ApoE knock-in mice, finding that ApoE4 mice exhibit significant cognitive deficits compared to ApoE3 mice in various cognitive tests, indicating an intrinsic vulnerability in ApoE4 mice that may be exacerbated in the context of neurodegenerative diseases.

Pages